SU625612A3 - Способ получени эрголиновых соединений или их солей - Google Patents
Способ получени эрголиновых соединений или их солейInfo
- Publication number
- SU625612A3 SU625612A3 SU752144199A SU2144199A SU625612A3 SU 625612 A3 SU625612 A3 SU 625612A3 SU 752144199 A SU752144199 A SU 752144199A SU 2144199 A SU2144199 A SU 2144199A SU 625612 A3 SU625612 A3 SU 625612A3
- Authority
- SU
- USSR - Soviet Union
- Prior art keywords
- mixture
- acid
- solution
- chloroform
- ergoline
- Prior art date
Links
- 238000000034 method Methods 0.000 title description 9
- AWFDCTXCTHGORH-HGHGUNKESA-N 6-[4-[(6ar,9r,10ar)-5-bromo-7-methyl-6,6a,8,9,10,10a-hexahydro-4h-indolo[4,3-fg]quinoline-9-carbonyl]piperazin-1-yl]-1-methylpyridin-2-one Chemical class O=C([C@H]1CN([C@H]2[C@@H](C=3C=CC=C4NC(Br)=C(C=34)C2)C1)C)N(CC1)CCN1C1=CC=CC(=O)N1C AWFDCTXCTHGORH-HGHGUNKESA-N 0.000 title description 8
- 150000003839 salts Chemical class 0.000 title description 6
- 239000000203 mixture Substances 0.000 description 32
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 30
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 18
- 239000000243 solution Substances 0.000 description 17
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 15
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 12
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 11
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 10
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 9
- 239000012074 organic phase Substances 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 8
- 239000002253 acid Substances 0.000 description 8
- 239000008346 aqueous phase Substances 0.000 description 8
- 239000000706 filtrate Substances 0.000 description 8
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 7
- 150000001875 compounds Chemical class 0.000 description 7
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 6
- 150000001408 amides Chemical class 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 5
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 5
- ZAGRKAFMISFKIO-UHFFFAOYSA-N Isolysergic acid Natural products C1=CC(C2=CC(CN(C2C2)C)C(O)=O)=C3C2=CNC3=C1 ZAGRKAFMISFKIO-UHFFFAOYSA-N 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- ZAGRKAFMISFKIO-QMTHXVAHSA-N lysergic acid Chemical compound C1=CC(C2=C[C@H](CN([C@@H]2C2)C)C(O)=O)=C3C2=CNC3=C1 ZAGRKAFMISFKIO-QMTHXVAHSA-N 0.000 description 4
- -1 maleic Chemical class 0.000 description 4
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 4
- 239000000741 silica gel Substances 0.000 description 4
- 229910002027 silica gel Inorganic materials 0.000 description 4
- 229910052938 sodium sulfate Inorganic materials 0.000 description 4
- 235000011152 sodium sulphate Nutrition 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 3
- XBPCUCUWBYBCDP-UHFFFAOYSA-N Dicyclohexylamine Chemical compound C1CCCCC1NC1CCCCC1 XBPCUCUWBYBCDP-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 230000010933 acylation Effects 0.000 description 3
- 238000005917 acylation reaction Methods 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- CNDHHGUSRIZDSL-UHFFFAOYSA-N 1-chlorooctane Chemical compound CCCCCCCCCl CNDHHGUSRIZDSL-UHFFFAOYSA-N 0.000 description 2
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 239000012458 free base Substances 0.000 description 2
- 150000004820 halides Chemical class 0.000 description 2
- MNWFXJYAOYHMED-UHFFFAOYSA-N heptanoic acid Chemical compound CCCCCCC(O)=O MNWFXJYAOYHMED-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 description 2
- 239000012264 purified product Substances 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 239000012359 Methanesulfonyl chloride Substances 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 239000000908 ammonium hydroxide Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 239000012024 dehydrating agents Substances 0.000 description 1
- XBPCUCUWBYBCDP-UHFFFAOYSA-O dicyclohexylazanium Chemical compound C1CCCCC1[NH2+]C1CCCCC1 XBPCUCUWBYBCDP-UHFFFAOYSA-O 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- UCVODTZQZHMTPN-UHFFFAOYSA-N heptanoyl chloride Chemical compound CCCCCCC(Cl)=O UCVODTZQZHMTPN-UHFFFAOYSA-N 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- REEZZSHJLXOIHL-UHFFFAOYSA-N octanoyl chloride Chemical compound CCCCCCCC(Cl)=O REEZZSHJLXOIHL-UHFFFAOYSA-N 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000012047 saturated solution Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 235000010288 sodium nitrite Nutrition 0.000 description 1
- 239000012258 stirred mixture Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
- C07D457/04—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
- C07D457/06—Lysergic acid amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
- C07D457/02—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hydrocarbon or substituted hydrocarbon radicals, attached in position 8
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Psychiatry (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HUGO1272A HU169073B (enExample) | 1974-05-28 | 1974-05-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SU625612A3 true SU625612A3 (ru) | 1978-09-25 |
Family
ID=10996767
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SU752144199A SU625612A3 (ru) | 1974-05-28 | 1975-05-27 | Способ получени эрголиновых соединений или их солей |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US4005089A (enExample) |
| JP (1) | JPS5218718B2 (enExample) |
| AT (1) | AT346501B (enExample) |
| BE (1) | BE829518A (enExample) |
| BG (1) | BG27374A3 (enExample) |
| CA (1) | CA1051878A (enExample) |
| CS (1) | CS194227B2 (enExample) |
| DD (1) | DD121639A5 (enExample) |
| DE (1) | DE2523743A1 (enExample) |
| DK (1) | DK143801C (enExample) |
| ES (1) | ES437994A1 (enExample) |
| FI (1) | FI61897C (enExample) |
| FR (1) | FR2272671B1 (enExample) |
| GB (1) | GB1474337A (enExample) |
| HU (1) | HU169073B (enExample) |
| IL (1) | IL47361A (enExample) |
| NL (1) | NL7506276A (enExample) |
| PL (1) | PL98944B1 (enExample) |
| SE (1) | SE419548B (enExample) |
| SU (1) | SU625612A3 (enExample) |
| YU (1) | YU135575A (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4064249A (en) * | 1974-05-28 | 1977-12-20 | Richter Gedeon Vegyeszeti Gyar Rt. | Compounds with ergoline skeleton |
| HU172649B (hu) * | 1975-04-24 | 1978-11-28 | Gyogyszerkutato Intezet | Sposob poluchenija novykh biologicheski aktivnykh lizergamidov |
| HU172479B (hu) * | 1976-03-09 | 1978-09-28 | Gyogyszerkutato Intezet | Sposob poluchenija novykh soedinenij s ehrgolenovymi i |
| JPS577172Y2 (enExample) * | 1977-03-17 | 1982-02-10 | ||
| JPS582957U (ja) * | 1981-06-30 | 1983-01-10 | 松下電子工業株式会社 | 高圧ナトリウムランプ |
| IT1171432B (it) * | 1981-08-03 | 1987-06-10 | Fidia Farmaceutici | Amidi organiche derivate da lipidi azotati utilizzabili come farmaci |
| US4675322A (en) * | 1984-12-10 | 1987-06-23 | Eli Lilly And Company | 1-Substituted-6-n-propyl-8β-methylthio-methylergolines |
| DD238051A1 (de) * | 1985-06-10 | 1986-08-06 | Dresden Arzneimittel | Verfahren zur herstellung neuer lysergsaeureamide |
| SG181896A1 (en) * | 2009-12-23 | 2012-07-30 | Map Pharmaceuticals Inc | Novel ergoline analogs |
| CN103827113A (zh) | 2011-06-23 | 2014-05-28 | Map药物公司 | 新型氟麦角碱类似物 |
| EP2793580A4 (en) | 2011-12-19 | 2015-05-20 | Map Pharmaceuticals Inc | NEW DERIVATIVES OF ISO-ERGOLINE |
| US8946420B2 (en) | 2011-12-21 | 2015-02-03 | Map Pharmaceuticals, Inc. | Neuromodulatory compounds |
| US9012640B2 (en) | 2012-06-22 | 2015-04-21 | Map Pharmaceuticals, Inc. | Cabergoline derivatives |
| BR112017015487A2 (pt) | 2015-01-20 | 2018-01-30 | Xoc Pharmaceuticals Inc | Composto; composição; método de tratamento e/ou prevenção de enxaqueca, als, doença de alzheimer, doença de parkinson, distúrbios extrapirimidais, depressão, náusea, êmese, síndrome das pernas inquietas, insônia, agressão, doença de huntington, doença cardiopulmonar, fibrogênese, hipertensão arterial pulmonar, ansiedade, dependências a drogas, distonia, parassonia ou hiperlactinemia em um indivíduo; métodos de agonização dos receptores d2, 5-ht1d, 5-ht1a e 5-ht2c, em um indivíduo; método de antagonização do receptor d3 em um indivíduo; métodos de agonização seletiva dos receptores 5 -ht1d, e 5-ht2c, método de fornecimento de atividade de antagonista funcional no receptor 5 -ht2b ou no receptor 5-ht7, ou em ambos, em um indivíduo; método de fornecimento de atividade de antagonista funcional nos receptores adrenérgicos em um indivíduo |
| CA3064274A1 (en) | 2017-06-01 | 2018-12-06 | Xoc Pharmaceuticals, Inc. | Ergoline derivatives for use in medicine |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2533699A (en) * | 1950-12-12 | Amines containing the king system | ||
| US2673850A (en) * | 1951-07-28 | 1954-03-30 | Sandoz Ag | Piperazides of the lysergic acid series |
| US2946796A (en) * | 1958-10-15 | 1960-07-26 | Grace W R & Co | Salts of ergot alkaloids |
| CH475252A (de) * | 1966-02-08 | 1969-07-15 | Sandoz Ag | Verfahren zur Herstellung neuer Lysergsäure-Derivate |
| US3901893A (en) * | 1970-05-18 | 1975-08-26 | Richter Gedeon Vegyeszet | New dihydro-lysergic acid derivative |
| SE396753B (sv) * | 1970-05-18 | 1977-10-03 | Richter Gedeon Vegyeszet | Analogiforfarande for framstellning av en forening tillhorande dihydrolysergsyraserien |
| IL41409A (en) * | 1972-02-04 | 1977-04-29 | Richter Gedeon Vegyeszet | Lysergic acid amides and process for their preparation |
-
1974
- 1974-05-28 HU HUGO1272A patent/HU169073B/hu unknown
-
1975
- 1975-05-21 AT AT386375A patent/AT346501B/de not_active IP Right Cessation
- 1975-05-22 US US05/579,979 patent/US4005089A/en not_active Expired - Lifetime
- 1975-05-23 GB GB2283775A patent/GB1474337A/en not_active Expired
- 1975-05-25 YU YU01355/75A patent/YU135575A/xx unknown
- 1975-05-26 BG BG030088A patent/BG27374A3/xx unknown
- 1975-05-26 IL IL47361A patent/IL47361A/xx unknown
- 1975-05-26 DD DD186250A patent/DD121639A5/xx unknown
- 1975-05-26 SE SE7505974A patent/SE419548B/xx unknown
- 1975-05-27 FI FI751537A patent/FI61897C/fi not_active IP Right Cessation
- 1975-05-27 FR FR7516377A patent/FR2272671B1/fr not_active Expired
- 1975-05-27 PL PL1975180710A patent/PL98944B1/pl unknown
- 1975-05-27 BE BE156729A patent/BE829518A/xx not_active IP Right Cessation
- 1975-05-27 SU SU752144199A patent/SU625612A3/ru active
- 1975-05-27 DK DK235175A patent/DK143801C/da not_active IP Right Cessation
- 1975-05-27 CA CA227,849A patent/CA1051878A/en not_active Expired
- 1975-05-28 ES ES437994A patent/ES437994A1/es not_active Expired
- 1975-05-28 DE DE19752523743 patent/DE2523743A1/de not_active Withdrawn
- 1975-05-28 CS CS753741A patent/CS194227B2/cs unknown
- 1975-05-28 JP JP50063984A patent/JPS5218718B2/ja not_active Expired
- 1975-05-28 NL NL7506276A patent/NL7506276A/xx not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| DK143801C (da) | 1982-03-22 |
| AT346501B (de) | 1978-11-10 |
| US4005089A (en) | 1977-01-25 |
| CS194227B2 (en) | 1979-11-30 |
| FI751537A7 (enExample) | 1975-11-29 |
| YU135575A (en) | 1982-06-30 |
| BG27374A3 (bg) | 1979-10-12 |
| CA1051878A (en) | 1979-04-03 |
| BE829518A (fr) | 1975-09-15 |
| JPS5218718B2 (enExample) | 1977-05-24 |
| IL47361A0 (en) | 1975-07-28 |
| FI61897B (fi) | 1982-06-30 |
| SE419548B (sv) | 1981-08-10 |
| FI61897C (fi) | 1982-10-11 |
| JPS516998A (enExample) | 1976-01-20 |
| DK143801B (da) | 1981-10-12 |
| DE2523743A1 (de) | 1975-12-18 |
| SE7505974L (sv) | 1975-12-01 |
| GB1474337A (en) | 1977-05-25 |
| NL7506276A (nl) | 1975-12-02 |
| DD121639A5 (enExample) | 1976-08-12 |
| AU8142575A (en) | 1976-11-25 |
| DK235175A (da) | 1975-11-29 |
| IL47361A (en) | 1979-11-30 |
| ATA386375A (de) | 1978-03-15 |
| FR2272671A1 (enExample) | 1975-12-26 |
| PL98944B1 (pl) | 1978-05-31 |
| ES437994A1 (es) | 1977-01-16 |
| HU169073B (enExample) | 1976-09-28 |
| FR2272671B1 (enExample) | 1978-10-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SU625612A3 (ru) | Способ получени эрголиновых соединений или их солей | |
| KR100442717B1 (ko) | 세프디니르의 결정성 아민 염 | |
| NO151876B (no) | Fremgangsmaate og anordning for foring av dyr | |
| SU604493A3 (ru) | Способ получени амидов лизергиновой кислоты или их солей | |
| EA006393B1 (ru) | Способ синтеза тропенола для его получения в промышленном масштабе | |
| JPS63310882A (ja) | ポリ酸素化されたラブダン誘導体及びその製造法 | |
| NO128533B (enExample) | ||
| SU558644A3 (ru) | Способ получени имидазолов или их солей | |
| SU847923A3 (ru) | Способ получени 7 -/ -2-амино- 2-(Низший АлКилСульфОНилАМиНОфЕНил)- АцЕТилАМиНО/-3МЕТОКСи-3-цЕфЕМ-4- КАРбОНОВыХ КиСлОТ или иХ СОлЕй | |
| US3822268A (en) | Lysergic acid amides | |
| US3583992A (en) | 1-methyl-d-lysergic acid-dihydroxy-alkyl-amides | |
| SU417944A3 (ru) | Способ получения алкалоидов | |
| US3227709A (en) | Derivatives of cephalosporin c and process | |
| SU543355A3 (ru) | Способ получени производных глюкозы | |
| US2447361A (en) | dl-nu-cyclohexylacetylserine hexahydrobenzyl amide | |
| US3161634A (en) | Process of making nu-acyl derivatives of 6-amino-penicillanic acid | |
| US3983109A (en) | Process for recovering cephalosporin C from A fermentation broth as the N-(p-nitrobenzoyl) derivative | |
| SU593660A3 (ru) | Способ получени производных замещенной -аминооксигидроксамоновой кислоты | |
| SU922108A1 (ru) | Способ получени производных 6-метил-8 @ -гидразинометилэрголина или их солей | |
| EP0260588A1 (en) | Process for the preparation of alpha-N-[(hypoxanthin-9-yl)-pentyloxycarbonyl]-arginine | |
| SU1075973A3 (ru) | Способ получени мэйтансиноидов | |
| US4113948A (en) | 1-amino-1-phthalidyl alkanes and a method for producing same | |
| US4526991A (en) | 2,6-Dioxa-bicyclo-[2,2,2]-octane-7-yl-acetaldehydes | |
| GB2170806A (en) | N-(b-mercapto-iso-butyryl)proline, derivatives and a process for their preparation | |
| CA2006665C (en) | Process for purification of 1,2-bis (nicotinamido) propane |